|Articles|April 1, 2016
- BioPharm International-04-01-2016
- Volume 29
- Issue 4
BioPharm International, April 2016 Issue (PDF)
Click the title above to open the BioPharm International April 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 10 years ago
Modeling the Efficacy of HTST for Inactivating Mouse Minute Virusalmost 10 years ago
Continuous Processing for the Production of Biopharmaceuticalsalmost 10 years ago
Integrating Technology Transfer and Facilities Startup for Biologicsalmost 10 years ago
Essentials in Bioassay Design and Relative Potency Determinationalmost 10 years ago
Lessons Learned Accelerate Vaccine Developmentalmost 10 years ago
A Review of the Challenges of Delivering Macromolecule Biologicalsalmost 10 years ago
Platform Approach Speeds Process Developmentalmost 10 years ago
Behind the Scenes in Vaccine Developmentalmost 10 years ago
Size-Exclusion Chromatography for Preparative Purification of Biomoleculesalmost 10 years ago
Vaccine Development Faces Urgency and ChallengesNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
GSK’s Arexvy Gains EU Approval for Adults Aged 18 Years and Older
2
HanchorBio–WuXi Biologics Partnership Targets Fusion Protein Development Challenges
3
Optimizing Kinetics Assays to Avoid Avidity Effects
4
Industry Outlook 2026: Biopharma Industry Confronts Skills Shortage with Strategic Automation (Part 2)
5
